Latest News
PureTech Health investment Vor Biopharma raises $42m in funding round
Advanced biopharmaceutical company PureTech Health noted on Thursday that its affiliate, Vor Biopharma, had raised $42m in a Series A financing round.
US pre-open: Sino-US trade optimism to fuel more gains
US stocks looked set for more gains at the open on Thursday as optimism about Sino-US trade talks continued to underpin the mood.
Kropz ropes in mining veteran Jan Steenkamp at Elandsfontein project
Plant nutrient feed minerals producer Kropz announced the appointment of Jan Steenkamp as its managing director of its 74%-owned Elandsfontein phosphate development project in South Africa's Western Cape province on Thursday.
Utilitywise shares suspended as it calls in the administrators
Utilitywise announced on Thursday that Andrew James Johnson and Chad Griffin, both of FTI Consulting, had been been appointed as joint administrators to the firm.
London midday: Stocks maintain gains but Coca-Cola loses fizz on cautious outlook
London stocks were still in the green by midday on Thursday, underpinned by solid performances from the likes of Micro Focus and AstraZeneca, although Coca-Cola HBC lost its fizz as it struck a cautious note about the outlook.
Europe midday: Stocks hold gains after German, eurozone growth figures
European stocks were holding on to gains by midday on Thursday as investors waded through a raft of corporate releases and some key data on German and eurozone economic growth.
SkinBio seeking 'commercially experienced' CEO as business evolves
SkinBioTherapeutics on Thursday announced that it is seeking a "commercially experienced" replacement for Cath O'Neill, as she transitions away from the chief executive role during the current year.
Micro Focus bounces as it gets on top of HPE integration
Micro Focus said it was getting on top of the integration of the acquired HPE software business as it reported that the rate of revenue decline had eased off as last year went on and was expected to improve in 2019.
Eurozone economy inches ahead as Germany, Italy falter
The eurozone economy continued to grow in the fourth quarter, official figures out on Thursday showed, albeit marginally.
Augean wins slew of renewals and new customers
Augean on Thursday said it had renewed contracts, with terms of up to four years, with certain of its "strategically important" customers in Energy from Waste (EfW) and North Sea oil and industrial services.
Hardline Brexiters risk sending wrong signal to EU, says Fox
Hardline pro-Brexit MPs risked jeopardising a deal with the European Union because of “ideological purity”, said International Trade Secretary Liam Fox as parliament prepared for a another day of debate and non-binding votes.
AstraZeneca beats forecasts as new drug sales soar
AstraZeneca reported a strong fourth quarter, beating market expectations for revenues and earnings, with the drugs colossus guiding to another strong year ahead.
Chinese exports see surprise return to growth
Chinese exports unexpectedly rebounded in January, returning to growth and beating analyst forecasts, official statistics showed on Thursday.
Clarkson appoints William Thomas as chairman
Shipping services company Clarkson named technology industry veteran William Thomas as its next chairman on Thursday, following a thorough and independent search process.
Lancashire swings to profit despite higher levels of loss activity
FTSE 250 insurer Lancashire Holdings said on Thursday that it swung to a profit in 2018 despite higher levels of loss activity related to natural catastrophes.
Sabien continues to dive as sales conversions prove tricky
Sabien Technology dived on Thursday after a "challenging" period for the energy saving technology provider resulted in a drop in sales orders but losses were reduced through cost-cutting.
Germany narrowly avoids recession
Germany narrowly avoided a recession last year as growth in the fourth quarter was flat, according to preliminary data released by Destatis on Thursday.
Indivior unable to provide guidance amid Suboxone uncertainty
Indivior said it was unable to give investors an indication of revenue and profit for the current year due to uncertainty about how its star drug will affect by copycat versions.
Coca-Cola HBC achieves another year of currency-neutral growth
Coca-Cola HBC issued its financial results for the full year ended 31 December on Thursday, claiming its second year of foreign exchange-neutral revenue growth above its 4%-to-5% target range, with continued good progress towards its 2020 margin targets.
US and China resume trade talks ahead of looming deadline
US and Chinese officials will resume trade talks on Thursday all through Friday as the 1 March deadline to reach an agreement moves closer.